Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,022.00
+3.00 (0.29%)
Sep 23, 2026, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 186.92 billion as of September 25, 2026. Its market cap has decreased by -49.28% in one year.
Market Cap
186.92B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
19.11
Stock Price
1,022.00
ChartMarket Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 186.92B, an increase of 202.44%. That is a compound annual growth rate of 3.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 186.92B | -48.90% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suheung | 220.83B |
| Huons | 219.40B |
| Whan In Pharm | 185.95B |
| REYON Pharmaceutical | 184.88B |
| AptaBio Therapeutics | 181.48B |
| BNC KOREA | 180.22B |
| Chong Kun Dang Holdings | 178.28B |
| Samil Pharmaceutical Co.,Ltd | 173.10B |